Related Experiment Video
Updated: Sep 4, 2025

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
Inflammatory Myositis in a Child due to Anti-NXP2 Antibody, First Case Report from India
Ashok V Reddy Taallapalli1, Sumanth Shivaram1, Manisha Gupta1
1Department of Neurology, National Institute of Mental Health and Neuro sciences (NIMHANS), Hosur Road, Bengaluru, Karnataka, India.
Insights
This study reports a rare case of anti-nuclear matrix protein 2 (NXP2) antibody-mediated inflammatory myositis in a child. Early diagnosis and immunomodulatory treatment led to significant improvement, highlighting the importance of NXP2 antibody testing.
Area of Science:
- Pediatric Rheumatology
- Neuromuscular Disorders
- Autoimmune Diseases
Background:
- Inflammatory myopathies are rare autoimmune disorders affecting muscles.
- Anti-NXP2 antibody-associated myositis is a distinct subtype with specific clinical and imaging features.
- Early diagnosis and treatment are crucial for managing pediatric inflammatory myopathies.
Observation:
- A 10-year-old boy presented with proximal limb weakness, myalgias, contractures, and bulbar symptoms.
- Elevated creatine phosphokinase (CPK) and positive anti-nuclear matrix protein 2 (NXP2) antibodies were detected.
- Muscle MRI revealed active myositis with extensive signal changes in lower limb muscles.
Findings:
- The patient showed significant clinical improvement following treatment with steroids, intravenous immunoglobulins (IVIg), and mycophenolate mofetil (MMF).
- This case represents the first report of anti-NXP2 antibody-mediated inflammatory myositis from India.
- The findings underscore the utility of NXP2 antibody testing in pediatric myositis.
Implications:
- This case highlights the importance of considering anti-NXP2 antibody myositis in children with inflammatory muscle disease.
- Prompt immunomodulatory therapy can lead to favorable outcomes in anti-NXP2 antibody-positive patients.
- Further research is needed to understand the long-term prognosis and management strategies for this rare condition.
Abstract:
We present a case of a 10-year-old boy with 1-month history of proximal more than the distal weakness of all four limbs with myalgias, contractures, and bulbar symptoms on a background history of exertional myalgias for 2 years. His power was grade two-three. Investigations showed elevated creatine phosphokinase (CPK). His auto-antibody profile showed anti- nuclear matrix protein 2 (NXP2) antibody positivity. Muscle magnetic resonance imaging (MRI) showed extensive T2 fat-saturated hyperintense signal changes in the glutei, thigh, and leg muscles suggestive of active myositis. He improved significantly with immunomodulation with steroids, intravenous immunoglobulins (Iv Ig), and mycophenolate mofetil (MMF). He was continued on monthly pulse steroids and MMF. He is on regular follow-up. This is a rare case of anti-NXP2 antibody-mediated inflammatory myositis and the first report from India.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Myocarditis III: Medical Management